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Abstract
Background: Mitochondria are semi-autonomous, semi-self-replicating organelles harboring their own DNA
(mitochondrial DNA, mtDNA), and their dysregulation is involved in the development of various diseases. While
mtDNA does not generally undergo epigenetic modifications, almost all mitochondrial proteins are encoded by
nuclear DNA. However, the epigenetic regulation of nuclear-encoded mitochondrial genes (nuclear mt genes) has
not been comprehensively analyzed.
Results: We analyzed the DNA methylation status of 899 nuclear mt genes in the liver, brain, and heart tissues of
mouse, and identified 636 nuclear mt genes carrying tissue-dependent and differentially methylated regions
(T-DMRs). These nuclar mt genes are involved in various mitochondrial functions and they also include genes
related to human diseases. T-DMRs regulate the expression of nuclear mt genes. Nuclear mt genes with tissue-
specific hypomethylated T-DMRs were characterized by enrichment of the target genes of specific transcription
factors such as FOXA2 in the liver, and CEBPA and STAT1 in the brain.
Conclusions: A substantial proportion of nuclear mt genes contained T-DMRs, and the DNA methylation status of
numerous T-DMRs should underlie tissue-dependent mitochondrial functions.
Background
Mitochondrial dysfunction is a common cause of human
diseases [1,2], and thus understanding the regulation of
mitochondrial functions is critical. Mitochondria do not
contain histones [3], and almost all mtDNA is unmethy-
lated [4,5], indicating that mtDNA is not epigenetically
regulated. However, while mammalian mitochondria are
estimated to consist of more than 1,500 proteins, only
13 proteins are encoded by mtDNA.
Methylation of nuclear DNA is a major component of
epigenetic system in mammalian cells, and is involved in
silencing of gene transcription and maintaining genomic
stability [6,7]. Hypomethylation of regulatory regions is
required to allow expression of genes [8,9]. Microarray-
based DNA methylation analysis revealed the existence
of thousands of tissue-dependent and differentially
methylated regions (T-DMRs) in the mouse and human
genomes [10,11]. While the T-DMRs of some genes,
such as Oct-4 and Nanog, are hypomethylated only in
a few cells [12,13], the methylation status of most
T-DMRs is not specific, but common to certain cells or
tissues [11,14]. Tissue-dependent methylation status of
T-DMRs, including tissue-specific methylation status of
T-DMRs, forms a distinctive DNA methylation profile
for each cell type [8,11,15].
A nuclear mt gene, Ant4, which encodes mitochon-
drial outer membrane protein, contains T-DMRs which
is specifically hypomethylated in the testis [16,17]. Also,
few dozens of nuclear mt genes in mice are hypomethy-
lated in the liver relative to the cerebrum [11]. However,
the presence of T-DMRs in nuclear mt genes has not
been comprehensively analyzed; this is necessary for
understanding the regulation of mitochondrial functions.
In this study, we analyzed the DNA methylation of
899 nuclear mt genes in the liver, brain, and heart
tissues of mouse; these tissues consume large amounts
of energy and are highly susceptible to mitochondrial
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dysfunctions. Our results indicated that at least 636
nuclear mt genes, which account for 71% of the total
investigated nuclear mt genes, contain T-DMRs in their
transcription start site (TSS) flanking regions (-7~+3 kb
of TSSs), and that the differential methylation status of
these T-DMRs is associated with tissue-dependent mito-
chondrial functions.
Results and Discussion
Identification of T-DMRs in the TSS flanking regions of
nuclear mt genes in the liver, brain, and heart tissues
To investigate the DNA methylation status of nuclear
mt genes in the liver, brain (cerebrum), and heart tis-
sues, we conducted pairwise tissue comparisons using
model-based analysis of tiling-array (MAT) along with
D-REAM analysis [11,18]. Differences in the DNA
methylation status at HpyCH4IV sites (ACGT sites)
were exhibited as differences in MATscores of the
probes corresponding to the selectively amplified frag-
ments generated by digestion of unmethylated Hpy-
CH4IV sites [11]. We identified tissue-dependent and
differentially methylated HpyCH4IV sites within the
10 kb-TSS flanking regions of 899 RefSeq genes that are
known to encode mitochondrial proteins and are regis-
tered in the Mitop2 database as a reference set [19]. In
each tissue comparison, HpyCH4IV sites with MAT-
scores above a specific threshold value were identified as
hypomethylated T-DMRs in that particular tissue. The
lowest MATscore of HpyCH4IV sites whose hypo-
methylation were confirmed by combined bisulfite
restriction analysis (COBRA) (Figure 1A,B and Addi-
tional file 1,2), were considered as the threshold values
of MATscore. COBRA was performed for HpyCH4IV
sites whose MATscores were larger than 2 when one
tissue was compared to the either of the other 2 tissues.
We identified T-DMRs in the 10 kb-TSS flanking
regions of 636 nuclear mt genes (Figure 1C and Addi-
tional file 3), with 123, 119, and 99 nuclear mt genes
with T-DMRs specifically hypomethylated in the liver,
brain, and heart tissues, respectively, when compared
with the other 2 tissues (hereafter referred to as tissue-
hypo T-DMRs) (Figure 1C and Additional file 4).
Most functional categories of mitochondria classified
by Mitop2 were found in nuclear mt genes with
T-DMRs and with hypo T-DMRs (Figure 1D). Overre-
presentation and underrepresentation of nuclear mt
genes with liver-hypo T-DMRs were found in the detox-
ification and mitochondrial ribosomal categories, respec-
tively (P < 0.05, Fisher’s exact test; Figure 1D and
Table 1). Detoxification is one of the functions of the
liver. Nuclear mt genes with liver-hypo T-DMRs also
included the genes related to liver-specific functions,
namely, Otc and Lrpprc (Table 1). OTC functions in the
urea cycle in the liver [20]. LRPPRC is a binding partner
of PPARGC1A, and functions in hepatic gluconeogen-
esis [21]. Nuclear mt genes with T-DMRs contained a
number of genes involved in various types of mitochon-
drial regulation, such as the regulation of protein sort-
ing, mitochondrial morphology, and translation of
mtDNA-encoded proteins (Table 1).
Human homologs of mouse nuclear mt genes posses-
sing T-DMRs are related to various human diseases. For
example, mutations of Lrpprc, Ndufs4, and Ndufs8, the
genes with liver-, brain-, and heart-hypo T-DMRs,
respectively, are associated with Leigh’s disease [21-23].
In addition to mutations, overexpression of some
nuclear mt genes with liver-hypo T-DMRs in non-liver
tissues are involved in the human diseases. For example,
overexpression of Acsl5 and Tgm2 are found in the
human glioma and brain of Huntington’s disease and
are suggested to be involved in pathogenesis [24,25].
Correlation between the DNA methylation status of
T-DMRs and nuclear mt gene expression
Next, we examined the correlation between the DNA
methylation status of nuclear mt genes and their expres-
sion using microarray data downloaded from Gene
Expression Omnibus (Figure 2A and Additional file 5).
The liver-hypo T-DMRs positively correlated with the
liver vs. cerebral cortex and liver vs. heart expression
ratios (Figure 2A). In the brain and heart, only the hypo
T-DMRs located downstream of TSSs positively corre-
lated with the ratio of the expression in hypomethylated
tissue vs. other tissue (Figure 2A and Additional file 5).
On the other hand, negative correlation was observed
between the upstream heart-hypo T-DMRs and the
heart vs. cerebral cortex expression ratio, although the
average expression levels were greater in the heart (Fig-
ure 2A). Thus, the downstream hypo T-DMRs corre-
lated with the expression of the nuclear mt genes in all
tissues examined. The correlation between T-DMRs
around TSSs and tissue-specific gene expression coin-
cided with that in the previous reports [11,15,26,27]. We
confirmed the tissue-dependent gene expression of Otc,
Acsl6, and Ndufs4, the genes carrying downstream hypo
T-DMRs for liver, brain, and heart, respectively, by
using real-time PCR (Figure 2B).
Concentration of liver-hypo T-DMRs in the downstream
regions of nuclear mt genes
In addition to the highest correlation of downstream
liver-hypo T-DMRs with nuclear mt gene expression
(Figure 2A and Additional file 5), a significantly larger
proportion of the nuclear mt genes with liver-hypo
T-DMRs contained these hypo T-DMRs in their down-
stream regions as compared to the nuclear mt genes
with brain- and heart-hypo T-DMRs (P < 5 × 10-3, Fish-
er’s exact test; Figure 3A). Furthermore, in genes with
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downstream liver-hypo T-DMRs, the nuclear mt genes
were highly enriched (Figure 3B). Liver-hypo T-DMRs
were especially enriched within regions of +1~+2 kb of
TSSs of nuclear mt genes (Figure 3C). These results
indicate that regulation of nuclear mt genes is especially
dependent on DNA methylation in the liver.
Overrepresented transcriptional regulatory motifs in
nuclear mt genes with liver- and brain-hypo T-DMRs
We next investigated whether T-DMRs of nuclear mt
genes are associated with any transcriptional regulatory
motifs. FOXA2 is a transcription factor that activates
the genes involved in mitochondrial b-oxidation and the
Figure 1 Nuclear mt genes with T-DMRs identified by D-REAM analysis. (A) Differential methylation levels of HpyCH4IV sites for which the
relative hypomethylation levels were analyzed using the D-REAM analysis. For each HpyCH4IV site, the corresponding MATscore is indicated
along the horizontal axis. In each tissue comparison, the lowest MATscore of the HpyCH4IV sites whose hypomethylation were confirmed using
COBRA, was considered as a threshold value for detecting hypomethylated regions in the tissue comparison. Pale-colored circles indicate that
the corresponding HpyCH4IV site was not included in the hypo T-DMRs (see text for definition). (B) Matrices show the differential level of DNA
methylation of the liver-, brain-, and heart-hypo T-DMRs in the tissues relative to the respcective methylation level of hypo T-DMRs in the liver,
brain, and heart, respectively. Each column represents a different hypo T-DMR. The names of nuclear mt genes containing hypo T-DMRs in their
TSS flanking regions are displayed under each column. (C) Number of nuclear mt genes with T-DMRs. Matrix columns represent different nuclear
mt genes. (D) Function of nuclear mt genes, nuclear mt genes with T-DMRs and nuclear mt genes with liver-hypo T-DMRs. Pie charts illustrate
the percentage of genes that possess the indicated functions.
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regulation of lipid metabolism, ketogenesis, and insulin
sensitivity in the mouse liver [28,29]. We analyzed the
enrichment of genes containing FOXA2-binding sites
within an extended gene region (encompassing 10 kb
upstream of TSS and 1 kb downstream of the 3’ UTR)
using known genome-wide FOXA2-binding sites in the
mouse liver obtained by ChIP-sequencing [30]. We
found that the targets of FOXA2 were enriched 1.6-fold
in nuclear mt genes with liver-hypo T-DMRs relative to
all nuclear mt genes (P < 5 × 10-5, Fisher’s exact test).
Sixty-four out of 123 nuclear mt genes with liver-hypo
T-DMRs were the targets of FOXA2 (Additional file 6).
This is contrast to the previous report, which indicated
enrichment of target genes of HNF1 and/or HNF4 in
hypomethylated genes in the mouse liver [11].
We further analyzed the enrichment of specific regula-
tory motifs in nuclear mt genes with hypo T-DMRs by
using the oPOSSUM program [31]. We used all nuclear
mt genes as a background gene set, and analyzed both
5 kb upstream and downstream of TSSs of the genes
with hypo T-DMRs. The enrichment of the genes with
FOXA2-binding sites in their downstream region was
observed in the nuclear mt genes with liver-hypo
T-DMRs. (Table 2 and Additional file 7). It has been
reported that FOXA2-binding at distal downstream
region of TSS of CEBPA gene functions as an enhancer
in humans [32]. Hypomethylation of downstream
T-DMRs may enhance transcription by permitting tran-
scription factors access to target genes. We also found
that genes with NFYA-binding sites in their downstream
regions were enriched among the nuclear mt genes with
liver-hypo T-DMRs, and the genes with CEBPA- and
STAT1-binding sites in their upstream regions were
enriched among the nuclear mt genes with brain-hypo
T-DMRs (Table 2 and Additional file 7). These results
indicate that T-DMRs are associated with specific tran-
scription factors in a tissue-dependent manner. CEBPA
and STAT1 are reported to be involved in cortical neu-
rogenesis [33] and inflammatory responses in the brain
[34], respectively. It has been reported that CEBPA-null
mice showed decreased nuclear mt gene expression in
brown adipose tissue [35]. STAT1 also regulates nuclear
mt gene expression in T cells in response to IFN-g [36].
Hypomethylation of hypo T-DMRs of targets of these
transcription factors may permit transcription factors
access to the target genes, and hypermethylation of
these T-DMRs may be essential for secured repression
of the corresponding genes in other tissues.
Conclusion
At least 71% of investigated nuclear mt genes contains
T-DMRs, and the methylation status of T-DMRs corre-
lated with tissue-dependent expression of dozens of
nuclear mt genes. Considering that there are at least
200 different cell types in the mammalian body, the
total number of nuclear mt genes with T-DMRs will be
higher. The differences in protein composition of mito-
chondria are reported to reflect tissue-dependent
nuclear mt gene expression [37]. Our data suggest that
DNA methylation status of nuclear mt genes underlies
tissue-dependent mitochondrial functions.
Methods
Mice
C57BL/6N male mice were obtained from Charles River
Japan. Mice were euthanized at 12-13 week old, and tis-
sues were collected and frozen at -80°C until use. All
experiments using mice were carried out according to
the institutional guidelines for the care and use of
laboratory animals (Graduate School of Agriculture and
Life Sciences, The University of Tokyo).
Genomic DNA extraction
Genomic DNA was extracted as described previously
[11]. Briefly, tissue samples were homogenized, and
incubated with lysis solution (10 mM Tris-HCl at pH
8.0, 5 mM EDTA, 200 mM NaCl, 0.2% SDS, and
200 μg/mL proteinase K) at 55°C for 30 min, and were
Table 1 Nuclear mt genes with hypo T-DMRs
Liver-hypo T-DMRs Brain-hypo T-DMRs Heart-hypo T-DMRs
Various mitochondrial functions
Metabolism Abat, Acsl5, Oat, etc Dmgdh, Mthfd1, Star, etc Cpt1b, Efta, Pdk4, etc
Respiratory chain Atp5o, Ndufb2, etc Atp5l, Cox6, Ndufs8, etc Atp5l, Ndufs4, Sdhc, etc
TCA cycle Dlst Aco2, Dlst Ogdh
Detoxification Gsr, Hagh, Mgst1, Tst Gstk1
Tissue-specific mitochondrial functions Otc, Lrpprc
Protein sorting Immp1l Tomm7
Regulation of mitochondrial morphology Mfn1, Prelid1
Regulation of mtDNA Peo1
Translation of mtDNA-encoded proteins Lrpprc Mtif2, Mtif3 Mrrf, Tufm
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extracted with a phenol/chloroform/isoamylalcohol
(PCI) mixture (50 : 49 : 1), incubated with RNase for 30
min, and re-extracted with PCI. DNA was precipitated
with ethanol and dissolved in Tris-EDTA (TE) buffer
(pH 8.0).
D-REAM analysis
We used T-DMR profiling with restriction-tag mediated
amplification (D-REAM) analysis [11] to obtain tissue-
dependent and differentially methylated HpyCH4IV sites
within the TSS flanking regions of RefSeq genes. For
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Figure 2 Expression of nuclear mt genes with hypo T-DMRs. (A) Boxplots show the expression ratio (log2 ratio) of the nuclear mt genes.
Tissues used for comparisons are shown under the plots. “All” indicates that the plot shows the expression ratio of entire nuclear mt genes. “U”
and “D” indicate that the plot shows the expression ratio of nuclear mt genes with hypo T-DMRs in upstream regions and downstream regions,
respectively. The number of probe sets representing the expression levels of corresponding genes are displayed under the plot. P-values
obtained from the Wilcoxon test are indicated on the top of the plot. (B) Genes which were relatively highly expressed in the tissues where
downstream T-DMRs were hypomethylated, according to gene expression array data. Relative gene expression was confirmed using real-time
PCR and was normalized to the expression of ß-actin (Actb). Bar graphs show the results of real-time PCR. “ND” indicates that the expression was
not detected under the experimental condition used. Experiments were performed in biological duplicates, and all amplification were performed
in triplicates. Error bars show standard deviations. For the Otc and Acsl6 genes, methylation levels of downstream hypo T-DMRs were examined
by COBRA, and the electrophoresis images obtained by MultiNA microchip electrophoresis system are shown.
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D-REAM analysis, HpyCH4IV-digested genomic DNA
was extracted with PCI, re-extracted with chloroform,
precipitated with ethanol and dissolved in TE (pH 8.0).
Using purified DNA (250 ng), following procedure of D-
REAM analysis was performed as described previously
[11]. Briefly, genomic DNA was digested by the methyl-
sensitive enzyme HpyCH4IV (New England Biolabs), fol-
lowed by ligation-mediated PCR, and subsequent hybri-
dization of DNA to a GeneChip Mouse Promoter 1.0R
Array (Affymetrix). Comparison of the resulting signals
from digested HpyCH4IV sites between different tissue
samples indicates the differential methylation level at a
given site.
D-REAM analysis was performed twice for each of the
biological duplicates of heart, and once for the liver and
brain in this study. For the liver and brain, we added sin-
gle D-REAM data set from our previous study using tis-
sues from different individual [11]. Correlation
coefficients of microarray probe intensities between bio-
logical duplicates were greater than 0.93. D-REAM data
obtained in this study has been deposited in the ArrayEx-
press database (accession number A-MEXP-791).
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Figure 3 Concentration of liver-hypo T-DMRs in downstream regions of nuclear mt genes. (A) Bar graphs show the ratio of genes with
downstream hypo T-DMRs in nuclear mt genes with hypo T-DMRs. (B) Bar graphs show the ratio of nuclear mt genes in all genes and genes
with hypo T-DMRs. (C) The vertical axis of the histograms indicate the average number of liver-hypo T-DMRs per gene. Gene sets represented in
histograms are indicated on the top-left of each graph.
Table 2 Transcription factors whose binding-sites were enriched in analyzed sequences
Gene set Analyzed sequences Transcription factor Number of targets Enrichment P value*
Liver-hypo 5 kb-downstream FOXA2 52 1.23 3.1 × 10-2
NFYA 29 1.44 3.6 × 10-2
Brain-hypo 5 kb-upstream CEBPA 59 1.21 2.3 × 10-2
STAT1 25 1.52 2.5 × 10-2
* P values represent results of Fisher’s exact test.
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Combined bisulfite restriction analysis (COBRA)
Genomic DNA was digested with HindIII (Takara).
Digested DNA (5 μg) was denatured with 0.3 M NaOH.
Sodium metabisulfite (pH 5.0) and hydroquinone were
added to a final concentration of 2.0 M and 0.5 mM,
respectively. The reaction mixture was incubated under
following conditions: 15 cycles of 95°C for 30 s and 50°C
for 15 min. Next, 1.77 volume of QG buffer was added to
the reaction mixture, and DNA was purified using a
Quiagen gel extraction kit (Qiagen), and eluted with 100
μl of elution buffer (EB). DNA was treated with 0.3 M
NaOH at 37°C for 15 min, precipitated using 6 M ammo-
nium acetate (pH 7.0) and ethanol, and dissolved in 200
μl TE (pH 8.0). For each bisulfite PCR, 2 μl of DNA solu-
tion was used as the template, and BIOTAQ HS DNA
polymerase (Bioline) was used for amplification. PCR was
performed under the following conditions: denaturation
at 95°C for 10 min followed by 43 cycles, each cycle com-
prising 95°C for 30 sec, 60°C for 45 sec, 72°C for 30 sec,
followed by 10 min at 72°C. All primers used in this
experiment are listed in Additional file 2. The PCR pro-
duct was digested with HpyCH4IV. Restriction-enzyme-
treated DNA was desalted using gel filtration through
Sephadex G-50, and was analyzed using the MultiNA
microchip electrophoresis system (Shimadzu). The
methylation level was calculated as the ratio of the
amounts of cut fragments to those of the total of cut and
uncut fragments obtained from the electropherograms.
RNA extraction, reverse transcription, and real-time PCR
Total RNA was prepared using TRIzol reagent (Invitro-
gen). Before synthesis of first-strand cDNA, the RNA
preparation was treated with RNase-free DNase I (Invi-
trogen) to eliminate any residual genomic DNA. The
total RNA was then converted into first-strand cDNA
using random hexamers and Superscript III First-Strand
Synthesis System for RT-PCR (Invitrogen). The obtained
cDNA were amplified and quantified in triplicates by
using the Quantitect SYBR Green PCR Kit (Qiagen)
with ABI 7500 Real Time PCR system (Applied Biosys-
tems). PCR was performed under the following condi-
tions: Incubation at 95°C for 10 min followed by 40
cycles of PCR, each cycle comprising 95°C for 15 sec
and 60°C for 1 min. All primers used in this experiment
are listed in Additional file 8. Standard curves were
obtained with serial dilutions of a pool of cDNA sam-
ples derived from each tissue.
Bioinformatics
MAT [18] was used to analyze the tiling array data
(.CEL files) and identify the hypomethylated regions
based on tiling probe signals, probe sequences, and copy
numbers. Original tiling probes were remapped to the
mouse genome assembly version mm9 (July 2007 build)
provided by UCSC genome database. For the quality
control of D-REAM analysis, we monitored the selective
amplification of HpyCH4IV-digested fragments for the
tilling array data of each sample (Additional file 9).
For expression analysis, data from the GeneChip
Mouse Genome 430 2.0 Array of liver, heart, and cere-
bral cortex tissues of C57BL/6N male mice (8-10 week
old; n = 2 for each tissue) were downloaded from Gene
Expression Omnibus (accession no. GSE10246). The
array image data (.CEL files) was processed by the factor
analysis for robust microarray summarization algorithm
(FARMS) with quantile normalization [38].
Enrichment analysis of specific transcription factor
targets was performed using oPOSSUM program [31].
This program analyzed the genes using one-to-one
human-mouse orthologs and detected promoter motifs
in the conserved regions. The top 10% of the non-cod-
ing conserved regions with an absolute minimum per-
cent identity of 70% in each 5 kb region upstream and
downstream of the TSSs were analyzed for vertebrate
promoter motifs with a matrix match threshold of 75%.
Additional material
Additional file 1: Figure S1 Differential methylation levels of
HpyCH4IV sites and the corresponding MATscores.
Additional file 2: Table S1 Primers used for COBRA, and the result
of the experiment.
Additional file 3: Table S2 Genomic locations of T-DMRs.
Additional file 4: Table S3 Genomic locations of hypo T-DMRs.
Additional file 5: FIgure S2 Expression ratio of nuclear mt genes
with hypo T-DMRs.
Additional file 6: Table S4 Genes with liver-hypo T-DMRs and
FOXA2-binding sites.
Additional file 7: Table S5 Genes with hypo T-DMRs and
overrepresented transcription factor binding sites.
Additional file 8: Table S6 Primers used for real-time PCR.
Additional file 9: Figure S3 Distribution of MATscores calculated
from D-REAM data of each tissue.
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